current
face
frighten
increas
patient
admit
icu
aim
screen
fungal
secondari
pneumonia
collect
data
first
icu
patient
underw
bronchoalveolar
lavag
bronchial
aspir
classifi
patient
base
recent
publish
studi
invas
aspergillosi
influenza
patient
schauwvlingh
et
al
found
patient
put
invas
pulmonari
aspergillosi
observ
high
preval
covidinfect
patient
somehow
unexpect
sinc
preval
invas
aspergillosi
influenza
patient
attribut
action
oseltamivir
antiaspergillu
immun
almost
critic
ill
patient
develop
ard
like
receiv
highdos
steroid
immunomodulatori
therapi
prevent
worsen
suggest
report
china
patient
put
invas
aspergillosi
antifung
prophylact
therapi
may
question
avoid
increas
lung
inflamm
may
compromis
outcom
issu
remain
address
futur
clinic
trial
strongli
convinc
test
deep
lung
specimen
aspergillu
sever
patient
recommend
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
parallel
report
influenza
patient
design
prospect
observ
bicent
studi
investig
risk
ipa
critic
ill
patient
especi
sinc
patient
like
receiv
immunomodulatori
therapi
patient
classifi
use
influenzaassoci
ipa
criteria
icu
complet
betadglucan
measur
quantit
realtim
pcr
qpcr
bal
put
ipa
consid
one
follow
condit
met
ie
aspergillu
fumigatu
cultur
galactomannan
index
betadglucan
pgml
aspergillu
fumigatu
qpcr
quantif
cycl
pulmonari
specimen
andor
betadglucan
serum
galactomannan
index
note
direct
examin
respiratori
specimen
perform
avoid
oper
contamin
twentyseven
success
mechan
ventil
patient
pneumonia
admit
march
th
th
two
icu
includ
tabl
aspergillu
patient
present
ill
may
differ
none
nine
put
ipa
patient
except
one
receiv
antiaspergillu
treatment
treat
patient
antifung
treatment
adapt
cover
candida
aspergillu
infect
ipa
group
three
fatal
relat
aspergillosi
bacteri
septic
shock
complic
multiorgan
failur
final
although
oseltamivirinduc
inhibit
host
neuraminidas
activ
suggest
possibl
molecular
mechan
lead
antiaspergillu
protect
immun
decreas
influenza
patient
exact
reason
increas
vulner
patient
aspergillu
remain
determin
well
aspergillu
contribut
lung
inflamm
author
declar
conflict
interest
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
